平台已收录预计检索 <10 秒
Preclinical Pharmacology Characterization of Sovleplenib (HMPL-523), an Orally Available Syk Inhibitor
查看已审核书目、规范引用与获取指引。下载与积分规则登录后查看。
文献信息
- 题目
- Preclinical Pharmacology Characterization of Sovleplenib (HMPL-523), an Orally Available Syk Inhibitor
- 作者
- Yu Cai, Jianlin He, Zhipeng Wu, Weigang He, Xiaoming Dai, Yan Xu, Min Cheng, Na Yang, Yongxin Ren, Guanglin Wang, Jian Wang, Yang Sai, Hong Jia, Guangxiu Dai, Xiong Li, Weiguo Su
- 发表年份
- 2024
- 期刊 / 来源
- The Journal of Pharmacology and Experimental Therapeutics
- 出版社
- American Society for Pharmacology and Experimental Therapeutics
- 文献类型
- 学术文献
- 平台记录更新
- 2026-09-16 10:58:54
本页由 Scihuhuan.com 学术互换提供文献检索、引用与获取指引;论文版权和出版身份归原出版方。
引用格式
同来源相关文献
Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease2021 · The Journal of Pharmacology and Experimental TherapeuticsAntiplatelet Agents Aspirin and Clopidogrel Are Hydrolyzed by Distinct Carboxylesterases, and Clopidogrel Is Transesterificated in the Presence of Ethyl Alcohol2006 · The Journal of Pharmacology and Experimental TherapeuticsHeparin-Binding Copolymer as a Complete Antidote for Low-Molecular-Weight Heparins in Rats2020 · The Journal of Pharmacology and Experimental TherapeuticsCarboxylesterase 1 as a Determinant of Clopidogrel Metabolism and Activation2013 · The Journal of Pharmacology and Experimental TherapeuticsThe Novel Kinase Inhibitor PRT062070 (Cerdulatinib) Demonstrates Efficacy in Models of Autoimmunity and B-Cell Cancer2014 · The Journal of Pharmacology and Experimental TherapeuticsActivation of Neuronal Voltage-Gated Potassium Kv7/KCNQ/M-Current by a Novel Channel Opener SCR2682 for Alleviation of Chronic Pain2021 · The Journal of Pharmacology and Experimental Therapeutics